The Motley Fool
04 Jul 2026, 15:45 UTC · 3h ago
State Street Health Care ETF Tops Invesco Pharma on Cost and Size
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
The Motley Fool
04 Jul 2026, 15:45 UTC · 3h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
3 claims · each scored for market impact
The Invesco Pharmaceuticals ETF (PJP) has delivered higher one-year and five-year returns compared to the State Street Health Care Select Sector SPDR ETF (XLV). — Stronger historical performance in a concentrated pharmaceutical basket suggests higher growth potential for the niche segment relative to the broad sector.
+0.30The State Street Health Care Select Sector SPDR ETF (XLV) offers significantly higher liquidity and a lower expense ratio (0.08%) than the Invesco Pharmaceuticals ETF (PJP). — Lower costs and higher volume make XLV a more efficient vehicle for large-scale institutional or conservative capital allocation.
+0.10The State Street fund (XLV) provides a higher dividend yield (1.6%) compared to the Invesco fund (0.9%). — A higher yield makes the broad healthcare ETF more attractive to income-focused investors in a volatile market.
+0.10Which stocks this story touches
Continue reading
6 related stories
Top 3 movers · tap to explore
Listed as a top holding in the PJP ETF with a positive price movement of 3.33%.
Mentioned as a top holding in the XLV ETF with a positive price movement of 3.35%.
Mentioned as a top holding in two healthcare ETFs with a positive price movement of 1.35%.
Listed as a top holding in both mentioned ETFs with a positive price movement of 3.90%.
[mutual] Both are primary holdings in the Invesco Pharmaceuticals ETF.
[mutual] Both are major holdings in the State Street Health Care Select Sector SPDR ETF.
[mutual] Both companies are key positions in the Invesco Pharmaceuticals ETF.
[mutual] Both are large-cap healthcare companies held in the same sector ETF.
[mutual] Both companies are large-cap pharmaceutical firms held within the same healthcare and pharmaceutical ETFs.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
The Motley Fool
4h ago
